Author: Michelle Valderama

Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance

Wensing AM, Charpentier C, Calvez V, et al. Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. Clin Infect Dis. 2025; https://doi.org/10.1093/cid/ciaf161. [epublished online April 3, 2025]

Guidelines
DETAIL

Episode 45 – Bacteriophages for the Treatment of Antimicrobial-resistant (AMR) Bacterial Infections with Dr Graham F. Hatfull

Episode 21 – New HIV Prevention: “What I’m Excited About” with Dr Raphael Landovitz

Podcasts
DETAIL

A Tough Nut to Crack? Update on Hepatitis B Cure

Presenter: David L. Wyles, MD

Key Slides . Podcasts . Webcasts
DETAIL

Year 13 of the Modern PrEP Era: A Spoon (Not a Fork) in the Road?

Presenter: Raphael J. Landovitz, MD, MSc

Key Slides . Podcasts . Webcasts
DETAIL

Ulcerative Sexually Transmitted Infections: Syphilis, Herpes Simplex Virus, Mpox, and Others

Presenter: Kimberly A. Workowski, MD

Key Slides . Podcasts . Webcasts
DETAIL

Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion

Presenter: Michael S. Saag, MD

Key Slides . Podcasts . Webcasts
DETAIL

Updates on HIV Primary Care

Presenter: Melanie A. Thompson, MD

Key Slides . Podcasts . Webcasts
DETAIL

Weight Management and GLP-1 Receptor Agonists for People With HIV: Insights and Strategies

Presenter: Darcy A. Wooten, MD

Key Slides . Podcasts . Webcasts
DETAIL

Key Updates From CROI 2025

Presenter: Jeffrey L. Lennox, MD

Key Slides . Podcasts . Webcasts
DETAIL

Resources: The IAS–USA Annual Update on HIV Management in Atlanta, Georgia

April 2, 2025

Key Slides . Webcasts
DETAIL